KALAMAZOO, Mich., Oct. 12 Stryker Corporation(NYSE: SYK) disclosed today that the United States Securities and ExchangeCommission has made an informal inquiry of the Company regarding possibleviolations of the Foreign Corrupt Practices Act in connection with the sale ofmedical devices in certain foreign countries. Stryker is fully cooperatingwith the U.S. Securities and Exchange Commission regarding this informalinvestigation.
Stryker Corporation is one of the world's leading medical technologycompanies with the most broadly based range of products in orthopaedics and asignificant presence in other medical specialties. Stryker works withrespected medical professionals to help people lead more active and moresatisfying lives. The Company's products include implants used in jointreplacement, trauma, craniomaxillofacial and spinal surgeries; biologics;surgical, neurologic, ear, nose & throat and interventional pain equipment;and endoscopic, surgical navigation, communications and digital imagingsystems; as well as patient handling and emergency medical equipment. For moreinformation about Stryker, please visit the company web site atwww.stryker.com.
SOURCE Stryker Corporation